About AGCP
Enabling Pharmaceutical Innovation Through Proprietary Nanotechnology
AGCP Farmaceuticos is a Portuguese pharmaceutical nanotechnology company providing proprietary drug delivery platforms to the global pharmaceutical industry through B2B technology licensing.
Our Mission
“Enabling pharmaceutical innovation through proprietary nanotechnology platforms.”
We believe that breakthroughs in drug delivery should be accessible to pharmaceutical companies of all sizes. Our B2B platform model removes the barrier of developing nanotechnology in-house, allowing our partners to focus on their therapeutic expertise while we provide the delivery technology.
Operating from our facility in Portugal, we combine pharmaceutical manufacturing with cutting-edge nanotechnology research to deliver commercially viable solutions for our partners.
3
Proprietary Platforms
Validated nanotechnology
PT
Portugal, EU
Manufacturing base
B2B
Platform Model
Technology licensing
47+
Years Combined
Leadership experience
Leadership Team
Experienced leaders combining deep pharmaceutical science expertise with proven business commercialization and M&A track records.
Lawrence Fine
CEO & Chairman
A seasoned technology executive and business strategist with 17 years at Microsoft, Lawrence brings extensive experience in M&A, commercialization, and building high-growth ventures from concept to exit.
Credentials
Dr. Alexander Dementev
President & CTO
A distinguished pharmaceutical scientist with over 30 years of research experience, Dr. Dementev is a pioneer in nano-suspension technology and the driving force behind AGCP's proprietary nanotechnology platforms.
Credentials
Company Milestones
Foundation
Company Established
AGCP Farmaceuticos founded in Caldas da Rainha, Portugal with focus on pharmaceutical nanotechnology.
R&D
Platform Development
Development and validation of three core nanotechnology platforms for pharmaceutical drug delivery.
Validation
Stability Demonstrated
18+ months stability data validated for nanoemulsion platforms; 4+ years for CBD formulations.
Quality
Quality Standards Established
Implemented rigorous pharmaceutical quality systems for nanotechnology production.
Current
Commercial Partnerships
Actively pursuing pharmaceutical licensing partnerships and strategic investment for platform expansion.
Our Facilities
Based in Lisbon, Portugal at the University of Lisbon's Tec Lab, our manufacturing facility provides the foundation for pharmaceutical-grade nanotechnology production.
AGCP Farmaceuticos, LDA
Lisbon, Portugal
University of Lisbon, Tec Lab
Lisbon
Portugal
Join Our Mission
Partner with AGCP to bring next-generation nanotechnology drug delivery to the pharmaceutical market. We welcome partnership and investment inquiries.